Addressing Risks Associated with IV Push Medication Use in Adults
While much emphasis has been placed on the improvement of IV infusion safety, there remains a limited amount of standardized safe practices associated with IV push injection safety. Recent ISMP survey data has revealed continued significant risk associated with the preparation and administration of IV push medications in clinical locations. This symposium will describe the need to replace old practices with new paradigms and will educate participants about the Institute for Safe Medication Practices (ISMP) Guidelines for Safe Practice of Adult IV Push Medications, which were developed a national, multidisciplinary, invitational summit held by ISMP. At this symposium, medication safety experts will discuss strategies for identifying and addressing the risks associated with IV push injection, including those associated with management of doses during drug shortages, unsafe unit-based preparation, unsafe injection practices, and limited training and guidance. A new gap analysis tool will be presented at the symposium that can be used by organizations to align best practices.
- Pharmacy Technicians
Following completion of this activity, participants will be able to:
- Identify the most common unsafe practices and at-risk behaviors associated with the unit-based preparation and administration of IV push medications to adults.
- Discuss safe practices associated with the use of IV push medications for adults.
- Describe the anticipated challenges to the implementation of ISMP's Safe Practice Guidelines for Adult IV Push Medications.
- Recognize the role of all stakeholders in the attainment of safe IV push practices in adults.
- Explain how to use an IV push gap analysis tool to perform an organizational assessment of risk.
Introduction and Overview:
Michael R. Cohen, RPh, MS, ScD (hon), DPS (hon), FASHP, President, ISMP
Understanding the Challenges and Risk Associated with IV Push Medication Use
Michelle Mandrack, MSN, RN, Director of Consulting Services, ISMP
ISMP Guidelines for Safe Practices: An Interdisciplinary Best Practice Approach
Susan Paparella, MSN, RN, Vice President, ISMP
This activity is supported by Baxter.
This CE activity is jointly provided by ProCE, Inc. and the Institute for Safe Medication Practices (ISMP). ProCE is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal Activity Number 0221-9999-18-376-L05-P/T has been assigned to this knowledge-based live CE activity (initial release date December 5, 2018). This CE activity is approved for 1.5 contact hours (0.15 CEU) in states that recognize ACPE providers. This CE activity is provided at no cost to participants. Successful completion of the online post-test and evaluation at www.ProCE.com no later than January 4, 2019 is required to receive CE credit. CE credit will be automatically uploaded to NABP/CPE Monitor upon completion of the post-test and evaluation. No partial credit will be given. Conflict of interest disclosures are required of all faculty and shall be provided to all participants at the conference.